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Abstract
Intra-tumour genetic heterogeneity is the result of ongoing evolutionary change within each cancer. The expansion of
genetically distinct sub-clonal populations may explain the emergence of drug resistance, and if so, would have prognostic
and predictive utility. However, methods for objectively quantifying tumour heterogeneity have been missing and are
particularly difficult to establish in cancers where predominant copy number variation prevents accurate phylogenetic
reconstruction owing to horizontal dependencies caused by long and cascading genomic rearrangements. To address these
challenges, we present MEDICC, a method for phylogenetic reconstruction and heterogeneity quantification based on a
Minimum Event Distance for Intra-tumour Copy-number Comparisons. Using a transducer-based pairwise comparison
function, we determine optimal phasing of major and minor alleles, as well as evolutionary distances between samples, and
are able to reconstruct ancestral genomes. Rigorous simulations and an extensive clinical study show the power of our
method, which outperforms state-of-the-art competitors in reconstruction accuracy, and additionally allows unbiased
numerical quantification of tumour heterogeneity. Accurate quantification and evolutionary inference are essential to
understand the functional consequences of tumour heterogeneity. The MEDICC algorithms are independent of the
experimental techniques used and are applicable to both next-generation sequencing and array CGH data.
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Introduction
The study of intra-tumour genetic heterogeneity (for short:
heterogeneity) is now a major focus of cancer genomics research
[1–12] due to its potential to provide prognostic information [13–15]
and to explain mechanisms of drug resistance [16–19]. Quantifying
tumour heterogeneity and understanding its aetiology crucially
depends on our ability to accurately reconstruct the evolutionary
history of cancer cells within each patient. In many cancers, such as
high-grade serous ovarian cancer (HGSOC), most of this heteroge-
neity is not reflected in point mutations but in genomic rearrange-
ments and endoreduplications that lead to aberrant copy-number
profiles [20,21]. In these cases tree inference is hindered by unknown
phasing of parental alleles and horizontal dependencies between
adjacent genomic loci. Therefore heterogeneity and evolutionary
divergence are typically quantified using ad-hoc thresholds [19] and
tree inference is often done subjectively [11]. Approaches developed
to address this problem include a graph theoretical approach on
signed reversals to order rearrangement events [22], but this requires
detailed annotation of rearrangements in the data that may not be
available, and the algorithm does not generally infer global trees
representing cancer evolution within a patient. The TuMult
algorithm [23] deals with underlying computational complexity by
considering only breakpoints — locations on the genome where the
copy-number changes — and by using total copy-number without
phasing of parental alleles. While simplifying the computational
problem, this approach discards potentially informative data.
Our aim is to establish numerical quantification of tumour
heterogeneity per patient from copy-number profiles that can
routinely be acquired from clinical samples. To this end, we have
developed MEDICC (Minimum Event Distance for Intra-tumour
Copy-number Comparisons), a method for accurate inference of
phylogenetic trees from unsigned integer copy-number profiles.
MEDICC specifically addresses the following challenges associated
with copy-number-based phylogeny estimation:
1. It makes use of the full copy-number information across both
parental alleles by phasing copy-number variants, i.e. assigning
them to one of the two physical alleles such that the overall
evolutionary distance is minimal.
2. It estimates evolutionary distances, thereby dealing with horizontal
dependencies between adjacent genomic loci and with multiple
overlapping events by using efficient heuristics. It therefore works
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on complete copy-number profiles instead of breakpoints which
allows the reconstruction of ancestral genomes.
3. It implements statistical tests for molecular clock (homogeneous
branch lengths), star topology (phylogenetic structure) and tests
for the relationship between clonal subpopulations to provide
informative summary statistics for the reconstructed evolutionary
histories and tumour heterogeneity.
MEDICC was designed to work on integer copy-number pro-
files that can routinely be obtained from single nucleotide poly-
morphism (SNP) arrays [24] or paired-end sequencing [25,26]. In
both cases DNA content is quantified relative to a diploid normal
in windows along the genome. SNPs distinguish the two parental
alleles via the B-allelic frequency, i.e. the amount of DNA assigned
to the B allele relative to the total DNA amount at that specific
genomic locus. The resulting profile comprises two vectors of
integer copy-numbers, representing the absolute number of copies
of that particular genomic segment in the two alleles. However,
without any external linkage information these vectors contain no
information about which copy-numbers belong together on the
same allele [11]. By convention (and for each genomic segment
independently), the larger of the two copy-numbers is termed the
major and the other the minor copy-number (Figure 1 left). The
process of finding the correct assignment of major and minor
copy-number to the two parental alleles is called phasing. In con-
trast to nucleotide substitution models where sites in a sequence
are modelled as independent and identically distributed [27],
copy-number events often overlap and range across many adjacent
genomic regions. Therefore, finding the correct phasing is essential
to accurately estimate evolutionary distances (Figure 2A), which
additionally requires a model capable of dealing with these hori-
zontal dependencies.
We developed MEDICC and successfully applied it to the
analysis of a novel dataset of 170 copy-number profiles of patients
undergoing neo-adjuvant chemotherapy for HGSOC as described
in our accompanying clinical study [28]. In the following we give a
more detailed description of the data and problems that MEDICC
addresses. We then introduce the MEDICC modelling framework
that guides all steps of the algorithm and which is then explained
in detail. We finish with a demonstration of MEDICC on a real-world
example of a case of endometrioid cancer and give simulation results
that compare it to competing methods.
Author Summary
Cancer is a disease of random mutation and selection
within the cellular genomes of an organism. As a result,
when advanced disease is diagnosed, the cells comprising
the tumour show a great amount of variability on the
genomic level, a phenomenon termed intra-tumour
genetic heterogeneity. Heterogeneity is thought to be
one of the main reasons why tumors become resistant to
therapy, and thus hinders personalised medicine ap-
proaches. If we want to understand tumour heterogeneity
and its connection to resistance development we need to
quantify it, which implies reconstructing the evolutionary
history of cancer within the patient. Unfortunately, so far,
methods for accurate reconstructions of these particular
evolutionary trees and for quantification of heterogeneity
have been missing. We here present MEDICC, a method
that uses a minimum evolution criterion to compare
cancer genomes based on genomic profiles of DNA
content (copy-number profiles). It enables accurate recon-
struction of the history of the disease and quantifies
heterogeneity. It is specifically designed to deal with
diploid human genomes, in that it disentangles genomic
events on both parental alleles and includes a variety of
accompanying algorithms to test for shapes of the
evolutionary trees as well as the rate at which the cancer
evolves.
Figure 1. Evolutionary copy-number trees are reconstructed in three steps. 1) After segmentation and compression, major and minor
alleles are phased using the minimum event criterion. 2) The tree topology is reconstructed from the pairwise distances between genomes. 3)
Reconstruction of ancestral genomes yields the final branch lengths of the tree, which correspond to the number of events between genomes.
doi:10.1371/journal.pcbi.1003535.g001
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Results
Given multiple such evolutionarily-related copy-number profiles, for
example from distinct primary and metastatic sites of the same patient,
phylogenetic inference in MEDICC then involves three steps: (i) allele-
specific assignment of major andminor copy-numbers, (ii) estimation of
evolutionary distances between samples followed by tree inference and
(iii) reconstruction of ancestral genomes (Figure 1). All three steps are
guided by a minimum evolution criterion. Similar to edit-distances for
sequence analysis [29], MEDICC counts the number of genomic
events needed to transform one copy-number profile into another and
searches for the tree that minimises this criterion.
MEDICC reconstructs evolutionary histories via a
minimum evolution criterion
We model the evolution of copy-number profiles through a series
of simple operations that increase or decrease copy-numbers by one
(Figure 3A). They map to real genomic rearrangements that have an
observable effect on copy-number profiles in the following way:
terminal and interstitial deletions, as well as unbalanced transloca-
tions, are single deletion events; tandem and inverted duplications
are single amplification events; and breakage fusion bridges are dual
events involving a duplication and a deletion (copy number decrease
on one locus and increase on the second) [22]. We use a finite-state
automaton (FSA) representation of genomic profiles and finite-state
transducers (FST) [30] for modelling and efficient computing of the
minimum-event distance based on these genomic events (Figure 3B).
Transducers have earlier been proposed as an efficient way of
modeling indels on trees [31–33], a problem closely related to the
one discussed here. Before going through the three steps of the
reconstruction process in detail it is necessary to introduce some
terminology; for a more thorough introduction into transducer
theory see [30,34,35] and references therein.
The MEDICC modelling framework. MEDICC models
diploid genomic copy-number profiles as sequences over the
Figure 2. Parental alleles are phased using context-free grammars. A) Allelic phasing is achieved by choosing consecutive segments from
either the major or minor allele which minimise the pairwise distance between profiles. B) The set of all possible phasing choices is modelled by a
context-free grammar. In this representation, the order of the regions’ copy-number values on the second allele is reversed, in order to match the
inside-out parsing scheme of CFGs. That way every possible parse tree of the grammar describes one possible phasing.
doi:10.1371/journal.pcbi.1003535.g002
Figure 3. Efficient distance calculation is enabled via a transducer architecture. A) Overlapping genomic rearrangements modify the
associated copy-number profiles in different ways. Amplifications are indicated in green, deletions in red. The blue rectangles indicate the previous
event. B) The one-step minimum event transducer describes all possible edit operations achievable in one event. This FST is composed n times with
itself to create the the full minimum event FST T . Edge labels consist of an input symbol, a colon and the corresponding output symbol, followed by
a slash and the weight associated with taking that transition. C) The minimum event FST T is asymmetric and describes the evolution of a genomic
profile from its ancestor. Composed with its inverse this yields the symmetric minimum event distance D.
doi:10.1371/journal.pcbi.1003535.g003
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alphabet S~f0, . . . ,K ,Xg, where f0, . . . ,Kg represent integer
copy-numbers (K is the maximum haploid copy-number) and X is
a special character that separates the two alleles on which events
can happen independently. For example, the profile
1123002X0122002 represents a chromosome with 7 regions
distinguished, with the first region present in one copy on one
allele and absent in the other allele; the second region present in
one copy on each allele; and so on up to the seventh region present
in two copies on each allele. This means that MEDICC deals with
a maximum total copy-number of 2K in a diploid genome. By
default 2K~8 which is the upper end of the dynamic range of
SNP arrays, but the alphabet can be extended easily without
changing the implementation. In this manuscript the terms
‘‘sequence’’ and ‘‘(copy-number) profile’’ are used interchangeably.
Copy-number profiles are implemented as acceptors, unweight-
ed finite-state automata that can contain a single or multiple such
profiles. The minimum-event distance is computed using a
weighted finite-state transducer [30]. FSTs are an extension of
FSAs with input and output symbols — like pair-HMMs, they
emit or accept two sequences simultaneously, meaning they model
the events transforming on sequence into another. Both FSAs and
FSTs can be equipped with weights from a semiring, enabling
calculations to be weighted according to some importance crite-
rion. One of the most common semirings is the real semiring (e.g.
the weights represent probabilities), where weights are multiplied
along a path in the automaton and the total weight of a sequence
(or pair of sequences) is the sum (total probability) over all possible
paths generating that sequence. Equally popular is the tropical
semiring, also known as the Viterbi path, where weights are
summed along a path and the total weight is the minimum across
all those paths. In this case weights are often ‘‘penalties’’ or neg-
ative log-probabilities for taking a certain path, similar to classical
pairwise sequence alignment in which mismatches and indels are
penalised with additive fixed scores.
MEDICC uses the tropical semiring for computing the mini-
mum event distance, but the modularity of the framework allows
us to smoothly transition to probabilities at a later stage by switch-
ing semirings without changing the algorithm. In this tropical
semiring a FST T1 then assigns a score to two sequences (rep-
resented as acceptors) x and z via
T1½x,z~min
p[P
X
i
w(p,i):
where P is the set of all possible paths through the FST in which
the input and output symbols match with the sequences x and z
and w(p,i) is the weight of that path at position i in the sequence.
No score is returned for a pair of sequences for which no valid
path in T1 exists. This leads to the definition of the minimum-
event distance, which governs all three steps of the reconstruction
process.
Constructing the minimum-event distance for copy-
number profiles. Figure 3B shows the one-step transducer
T1 that we use to model single amplifications and deletions of
arbitrary length and that counts one event each time the
amplification or deletion state is entered. This is analogous to an
affine gap cost model in classical sequence alignment [36]. T1½x,z
therefore assigns to each pair of sequences (x,z) the minimum
number of events necessary to transform one sequence into another.
At this point, however, not all possible copy-number scenarios have
a valid path (e.g. one event can amplify ‘‘1’’ to ‘‘2’’ but not ‘‘1’’ to
‘‘3’’). To include all possible changes across multiple events, T1 is
composed K times with itself Mohri2004. In essence, composition
describes the chaining of FSTs, where the total weight of the
composed transducer is the total minimum score from the input
sequence x via intermediate sequences yi to the target sequence z:
T ½x,z~(T10:::0T1)½x,z
~ min
y1,...,yK{1
T1½x,y1zT1½y1,y2z . . .ð
zT1½yK{2,yK{1zT1½yK{1,zÞ
For example, to amplify a copy-number from 1 to 4 the shortest
path goes via two intermediate sequences (2 and 3) totalling three
events (1?2,2?3 and 3?4).
This composition gives rise to the FST T that strictly adheres
the modelled biological constraints such as no amplification from
zero. We call T the tree transducer: these biological constraints give
it a direction, and it is not guaranteed to return a distance for any
pair of copy-number profiles. For example, input profile 11111
can be transformed into 10001 via a single deletion, but not vice
versa as once an allele has been lost it cannot be regained.
As we are interested in the minimum evolutionary distance
between any two sequences x and z via their last common ancestor
(LCA) y, the final distance FST D is formed by composing T with
its inverse (Figure 3C, Schwarz2010), such that D computes the
distance from a leaf node to the LCA (T{1) and back (T ) to the
other leaf node:
D½x,z~(T{10T)½x,z
~min
y
T{1½x,yzT ½y,z 
In the real semiring, and equipped with probabilities, this would
be analogous to classical phylogenetic reconstructions where a
reversible model of sequence evolution is used to compute the
likelihood of the subtree containing sequences x and z as the
products of the individual likelihoods of seeing x and z given their
ancestor y and summing over all y [37]. In our case, D
equivalently computes the minimum number of events from x to
z via their LCA. This distance is symmetric and is guaranteed to
yield a valid distance for any pair of sequences. In the rest of the
paper, ‘‘distance’’ refers to this minimum-event distance, unless
stated otherwise.
MEDICC therefore computes an evolutionary distance between
two genomes based on a minimum evolution criterion via their
closest possible LCA. Due to composition of the tree transducer T
with its inverse, the resulting distance D is a dissimilarity score that
at the same time is also (the logarithm of) the shortest-path
approximation to a positive-semidefinite kernel score [38,33].
That means that the pointwise exponential of the estimated
distance matrix D^, S~exp({D^), is a positive-semidefinite
similarity matrix (with all eigenvalues §0). The entries of this
matrix are the values of the pairwise dot products of the sample
genomes in a high-dimensional feature space. This feature space
can be thought of as a space where every possible copy-number
profile defines one dimension and sample genome i is represented
by a numerical feature vector fi that contains an evolutionary
similarity score between the sample genome itself and each of
these reference profiles. The entries of the kernel matrix S are then
simply the dot products Si,j~vfi,fjw of the feature vectors fi and
fj . We term this space the mutational landscape in which spatial
distances correspond to evolutionary distances and on which we
can directly apply explorative analyses like PCA, classification with
support-vector machines and other machine learning techniques
[39]. We use OpenFST, an efficient implementation of transducer
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algorithms [40] to achieve exact distance computation in qua-
dratic time.
Following the minimum evolution principle, the overall objec-
tive is to find a tree topology including ancestral states that mini-
mises the total tree length, i.e. the total number of genomic events
along the tree. In the following we will describe how MEDICC
achieves this in its three step process.
Step 1: Evolutionary phasing of major and minor copy-
numbers. As copy-number-changing events can independently
occur on either or both of the parental alleles the phasing of major
and minor copy-numbers heavily influences the minimum tree
length objective. We use the evolutionary information between
samples to solve these ambiguities. Using our distance measure we
can choose a phasing between a pair of diploid profiles that
minimises the pairwise distance between them (Figure 2A). This
respects the distinct evolutionary histories of both alleles and finds
a phasing scenario in which the evolutionary trajectories between
both haploid pairs are minimal. From each pair of major and
minor input sequences we can generate up to 2L possible phasing
choices, where L is the length of the input profile (both alleles have
the same length). This is too many to evaluate exhaustively, so in
order to achieve a compact representation of diploid profiles we
make use of a context-free grammar (CFG). Our implementation
is related to the use of CFGs to model RNA structures, where
paired residues in stem regions are not independent [36].
In our copy-number scenario a CFG represents different allele
phasing choices (see Figure 2B right). At every position in the
diploid profile we have a choice of using the major as the first allele
and the minor as the second or (‘‘D’’) vice versa (Figure 2B left).
Each possible parse tree of the CFG then corresponds to one
phasing scenario out of the 2L possibilities. When the distance FST
reads the separator it is forced to return to the match state (initial
state), thus guaranteeing that the total distance to another profile
equals the sum of the distances of the two alleles with no events
spanning different alleles. We represent CFGs algorithmically by
pushdown-automata in the FST library [41].
While this approach works well for finding phasing scenarios
that minimise the distance between one pair of profiles, we aim to
find phasing scenarios that jointly minimise the distances between
all profiles in the dataset. To reduce the computational complexity
of this task we have found it necessary to employ a heuristic.
MEDICC searches for the single profile that has minimum sum of
distances to all sample profiles, that is, the geometric median,
through an iterative search. This profile is then compared again to
each individual profile and the shortest path algorithm yields the
choice of phasing that minimises the distance between each profile
and the centre. This approach is not guaranteed to return a
globally optimal phasing scenario, but has proven to perform very
well in simulations (93:3% correctly phased genomic loci; see
simulation section).
Step 2: Distances and tree reconstruction. Once the
alleles have been phased, pairwise evolutionary distances between
samples can be computed as the sum of the pairwise distances
between both alleles. MEDICC then uses the Fitch-Margoliash
algorithm [42] for tree inference from a distance matrix with or
without clock assumption. A test of clock-like events, available
using functionality in the accompanying R package MEDICCquant,
allows us to determine which tree reconstruction algorithm is most
appropriate (see the section on quantification of heterogeneity).
Step 3: Ancestral reconstruction and branch lengths. From
this point on we keep the topology of the tree fixed, and traverse
from its leaves to the root to infer ancestral copy-number profiles
and branch lengths. Ancestral reconstruction is possible because
cancer trees are naturally rooted by the diploid normal from which
the disease evolved. Reconstructing ancestral genomes allows us to
investigate e.g. the genomic makeup of the cancer precursor, the
LCA of all cancer samples in the patient. Events that across patients
frequently occur between the root of the tree and the precursor are
likely driver events of cancer progression. Ancestral reconstruction
also determines the final branch lengths of the tree. MEDICC
infers ancestral genomes for each allele independently using a
variant of Felsenstein’s Pruning algorithm [27].
In Felsenstein’s original algorithm the total score (likelihood/
parsimony score) of the tree is computed in a downward pass
towards the root and ancestral states are then fixed in a second
upward pass, successively choosing the most likely/most parsimo-
nious states. In our scenario, the algorithm begins by composing
each of the n terminal nodes with the tree transducer T , which
yields n acceptors holding all sequences reachable from that
terminal node and their respective distances. When moving up the
tree to the LCA of the first two terminal nodes the corresponding
acceptors are intersected. The resulting acceptor contains only
those profiles that were contained in both input acceptors and
their corresponding weights are set equal to the sum of the weights
of the profiles in the input acceptors. In a probabilistic framework
the resulting acceptor is equivalent to the conditional probability
distribution P(subtree(x,z) D LCA y)~P(xDy)P(zDy) for each pos-
sible LCA, where the sum of distances again is replaced by the
product of the conditional probabilities of seeing a leaf node given
its ancestor. This intersection will still contain the vast majority of
all possible profiles, but each with a different total distance, and
without those that are prohibited by biological constraints. For
example, the ancestor cannot have a copy-number of zero at a
position where any of its leaf nodes has copy-number w0, as
amplifications from zero are not allowed. Because after phasing
each leaf node is represented by an acceptor containing exactly
one diploid sequence, computing this set of possible ancestors is
computationally feasible. However, because during tree traversal
we need to compose these sets of possible profiles repeatedly with
the tree transducer T , the result would increase in size
exponentially because it has to account for all possible events of
arbitrary length at each position in all sequences. Therefore during
tree traversal, when two internal nodes have to be joined in their
LCA, MEDICC reduces each of them to a single sequence by
choosing those two sequences with smallest distance to each other.
This fixes the profiles for those two internal nodes. This procedure
is continued until all internal nodes are resolved. Once all
ancestral copy-number profiles have been reconstructed the final
branch lengths are simply the distances between the nodes
defining that branch in the tree.
MEDICC improves phylogenetic reconstruction accuracy
We assessed reconstruction accuracy using simulated data
generated by the SimCopy R package [43] (see Methods). Random
coalescent trees were generated with APE [44]. To create an
unbiased simulation scenario, genome evolution was simulated
using increasing evolutionary rates on the sequence level using
five basic genomic rearrangement events: deletion, duplication,
inverted duplication, inversion and translocation (for details see
Methods). Once the simulations were complete, copy-numbers
were counted for each genomic segment and these copy-number
profiles were used for tree inference using the following three
methods: i) BioNJ [45] tree reconstruction on a matrix of Euclidean
distances computed directly on the copy-numbers, ii) breakpoint-
based tree-inference using the TuMult software [23] and iii)
MEDICC. TuMult additionally requires array log-intensities as
input. In order to keep the comparisons unbiased, noiseless log
ratios simulating CGH array intensities for TuMult were directly
Quantification of Tumour Heterogeneity
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computed from the copy-number profiles. To assess the relative
abilities of the methods to correctly recover the evolutionary
relationships of the simulated copy-number profiles, reconstruction
accuracy was measured in quartet distance [46] between the true
and the reconstructed tree. Quartet distance was chosen as it only
considers topological differences; branch lengths have widely differ-
ent meanings in the methods tested and as such are not comparable.
This simulation strategy is based on basic biological principles,
independent of the methods compared and a priori does not favour
any of them. All simulations were repeated to cover a wide para-
meter range, yielding qualitatively similar results.
The simulation results clearly show the improvement in recon-
struction accuracy of MEDICC over naive approaches (BioNJ on
Euclidean distances) and competing methods (TuMult) (Figure 4A).
In general, reconstruction accuracies increase with increasing evolu-
tionary rates. Especially when the amount of phylogenetic informa-
tion is limited, MEDICC outperforms other methods by a significant
margin. This may be because of two reasons: firstly, in contrast to
other methods MEDICC is capable of phasing the parental alleles,
thereby making much more effective use of the phylogenetic
information compared to methods that work on total copy-number
alone. Secondly, due to efficient and accurate heuristics, MEDICC
can deal with the horizontal dependencies imposed by overlapping
genomic events of arbitrary size and accurately computes distances
between them.
To assess the accuracy of the implemented CFG-based phasing
method, for each reconstructed tree phased alleles were
compared to the original simulated alleles. MEDICC correctly
phased 92:9% of all genomic loci across all simulations
(Figure 4C). We additionally evaluated the runtime of the
complete algorithm on our simulation scenario which consisted of
100 genomic segments after compression and found it to take on
average 5 minutes for a full reconstruction on a UNIX based
Intel(R) Xeon(R) CPU E5-2670 at 2.60 GHz.
Evolutionary comparisons with MEDICC allow
quantification of tumour heterogeneity
Intra-tumour heterogeneity is a loose concept that describes
the amount of genomic difference between multiple cells or
samples of the same tumour. Two types of heterogeneity often of
interest are spatial and temporal heterogeneity. For example, spatial
differences might be observed from separate biopsies of a primary
cancer and a distant metastasis. Other changes may occur
between different time points, for example before and after
chemotherapy. Average distances between subsets of samples
might be computed by any method that returns dissimilarities
between samples by simple averaging. However, clinical datasets
are often noisy due to normal contamination and immune
response such as leukocyte infiltration. As for example a sample
with exceptionally low cellularity can lead to errors during
segmentation, more robust measures of distances between
aggregated subsets of samples are desirable that are not easily
skewed by outliers.
As described earlier, the matrix of pairwise minimum-event
distances inferred by MEDICC can directly be transformed into a
kernel matrix [38,33] which maps samples to a high-dimensional
mutational landscape. We reduce the dimensionality of this
landscape through kernel principal components analysis [47]
where we can use spatial statistics to derive numerical measures of
heterogeneity for each patient.
Temporal heterogeneity. We define temporal heterogeneity
as the evolutionary distance between the average genomic profiles
between any two time points (e.g. at biopsy before chemotherapy
and at surgery after chemotherapy in the case of neo-adjuvant
treatment). In the mutational landscape (see above) we are able to
directly compute the centre of mass of a set of genomic profiles
(which would not be possible by working with distances alone) (X
in Figure 5D). The center of mass WS of a set of points S in feature
space is defined as
WS~
1
l
Xl
i~1
W(xi)
where W(xi) is the feature space mapping of point xi and l is the
number of points. We can then define temporal heterogeneity as the
distance between the centres of mass of the samples from two time
points. Consider the blue and orange sets in Figure 5D, named B
andO with b and o elements respectively. Without loss of generality
we can assume our genomic profiles xi to be partitioned into the two
Figure 4. MEDICC improves reconstruction accuracy over competing methods. A) Simulations results show the improvement of
reconstruction accuracy for MEDICC over naive methods (BioNJ clustering on Euclidean distances between copy-number profiles, red) and competing
algorithms (TuMult, green). B) Allele phasing accuracy across the simulated trees. On average 92.9% of all genomic loci were correctly assigned to the
individual parental alleles. C) Density estimates of clonal expansion indices for neutrally evolving trees (red) and trees with induced long branches as
created by clonal expansion processes (blue) show the ability of MEDICC to detect clonal expansion.
doi:10.1371/journal.pcbi.1003535.g004
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sets such that B~fx1, . . . ,xbg and O~
fxbz1, . . . ,xbzog. The squared distance between the centers of
mass WB and WO of the two sets of genomic profiles in our feature
space, is then defined as:
jjWB{WOjj2~vWB,WBw{2vWB,WOwzvWO,WOw
~
1
b2
Xb
i,j~1
vW(xi),W(xj)w{
2
bo
Xb
i~1
Xbzo
j~bz1
vW(xi),W(xj)w
z
1
o2
Xbzo
i,j~bz1
vW(xi),W(xj)w~
1
b2
Xb
i,j~1
Sij{
2
bo
Xb
i~1
Xbzo
j~bz1
Sij
z
1
o2
Xbzo
i,j~bz1
Sij
where S again is the kernel or similarity matrix. An advantage of
this approach is that it is possible to replace WS with other robust
measures of the centre of mass (e.g. ignoring the single most distant
point). It should be noted that this general approach can be used for
determining distances between any partitions of the samples in the
dataset, for example between groups of samples taken from different
organs as a measure of spatial heterogeneity.
The clonal expansion index. Other complex aspects of
heterogeneity that cannot be easily derived from distances alone
include the ability of a tumour to undergo clonal expansions [16].
The model here is that if the majority of cancer cells are subject to
strong selection pressure, such as from chemotherapy, minor
subclones with a distinctive selective advantage may repopulate.
This subpopulation would be expected to coalesce early and will
show a greater than expected divergence (relative to neutral
evolution) from other remaining clones. This model is similar to
analyses of clonality in bacterial populations [48]. Traditional tests
for deviation from a neutral coalescent are typically based on
single polymorphic sites and often require information about the
number of generations [49]. As such information is not available
for clinical cancer studies, we therefore make a spatial argument
about clonal expansions. We assume that due to the large
population sizes of cancer cells, genetic drift is not significant. In a
setting of neutral evolution where all sequences have essentially the
same fitness, sequences randomly move across the mutational
landscape leading to a uniform distribution of sequences in that
space (Figure 5A) with no selective sweeps or clonal expansions. If
strong selective pressure favours specific mutations (Figure 5B),
sequences are more likely to survive and be sampled from the
favoured regions leading to local clustering of sequences on the
mutational landscape (Figure 5C).
Besag’s L(r) [50], a variance-stabilised transformation of
Ripley’s K(r) [51], is a function used in spatial statistics to test
Figure 5. MEDICC quantifies heterogeneity from the locations of genomes on the mutational landscape. A) If no or a homogeneous
selection pressure is applied, cells proliferate and die randomly across the mutational landscape, leaving the surviving cells spatially unclustered. B) If
the fitness landscape favours specific mutations (blue shaded areas), genomes inside those areas are more likely to survive, those outside more likely
to die. The ability of a tumour for a clonal expansion into distant fitness pockets depends on its mutation potential per generation (long orange
arrow). This leads to C) a situation where distinct subpopulations/clonal expansions are present in a tumour, indicating a generally high potential for
a tumour to adapt to changing environments. D) The mutational landscape additionally allows estimates of average distance between two
subgroups of samples, here before (blue) and after (orange) chemotherapy. The distance between the two subgroups is defined as the distance of
the robust centres of mass (blue and orange X). This robust centre of mass is computed omitting the single most distant point of each subgroup
(blue and orange samples in the orange and blue subgroups respectively), making the statistic more resistant towards outliers.
doi:10.1371/journal.pcbi.1003535.g005
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for non-homogeneity, i.e. spatial clustering, of points in a plane.
lK(r) describes the expected number of additional random points
within a distance r of a typical random point of an underlying
Poisson point process with intensity l. The empirical estimate of
Ripley’s K for n points with pairwise distances dij and average
density bl is defined as
K^(r)~
1bln
X
i=j
I(dijvr),
where I is the indicator function. In case of complete spatial
randomness (CSR), the expectation of K(r) is pr2. Besag’s L is
defined as L(r)~
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
K(r)=p
p
and under CSR has expectation linear
in r. Therefore plotting r{L^(r) can be used as a graphical
indication of deviation from CSR. We use a simulation approach
to estimate significance bands for L(r) [52].
The clonal expansion index CE for a dataset (typically samples
taken from a single patient) is then defined as the maximum ratio
between the distance of the observed L-value (Lo(r)) and the
theoretical L-value under CSR (Lt(r)) and one-half the width of
the two-sided simulated significance band C(r)u (u for upper
significance band):
CE~max
r
DLo(r){Lt(r)D
Cu(r){Lt(r)
 
ð1Þ
A value of CE v1 therefore suggests CSR in the point set,
whereas a CE value w1 indicates local spatial clustering. We
conducted coalescence simulations to confirm that the clonal
expansion index distinguishes between trees with normal and
elongated branch lengths between populations (black and red
distributions, Figure 4B).
Testing for star topology and molecular clock. Tree
reconstruction methods may or may not include assumption of a
molecular clock, and this may significantly influence the
reconstruction accuracy. It is of particular interest in cancer
biology whether evolution is governed by constant or changing
rates of evolutionary change. Furthermore, it is still debated
whether disease progression follows a (structured) tree-like
pattern of evolution or if subpopulations are emitted in radial
(star-like) fashion from a small population of stem-like progen-
itors (see [53]).
We implemented tests for tree-likeness and molecular clock in
the MEDICCquant package to help answer these questions. We
model genomic events x as generated from a Poisson process X
with rate r. The expected number of events is then linear in time:
E½X ~rt. Assuming r~1, where the process is not time-
calibrated, the observed distance X^ is the maximum likelihood
estimate (MLE) for the time of divergence. Under asymptotic
normality of the MLE we have that X^*N(t,t). Given a star
topology we find optimal branch lengths that minimise the
residual sum of squares between the optimised pairwise
distances x
opt
i and the measured pairwise distances X^i for branch
i. Under the null hypothesis of star-like evolution this sum of
squares
RSSstar~
Xn(n{1)=2
i~1
x
opt
i {X^ iffiffiffiffiffi
X^ i
p !2
is then x2-distributed with n(n{1)=2{n degrees of freedom,
where n is the number of samples studied, i.e. the number of
leaves in the tree. The degrees of freedom is derived from the
difference between the numbers of freely estimated distances
under the alternative hypothesis (n(n{1)=2 pairwise distances
among the n samples) and the null hypothesis (one for each of the
n branches in the star topology).
An analogous procedure can be used for testing whether a tree
follows a molecular clock hypothesis, in which it exhibits constant
evolutionary rates along all branches. In this case the distances D^i
of all leaf nodes from the diploid should be the same. We measure
the deviation of the D^i from their mean (m(D^)) by
RSSclock~
Xn
i~1
m(D^){D^iffiffiffiffiffi
D^i
p !2
Because branch lengths do not need to be optimised to a specific
topology, and we are only considering distances to the diploid, the
distribution in this case has n{1 degrees of freedom (the
difference between n such distances free to vary with no clock,
and one distance when there is a molecular clock).
Progression and heterogeneity in a case of metastatic
endometrioid adenocarcinoma
In the following section we demonstrate MEDICC on a case
from the CTCR-OV03 clinical study [54]. This case had
advanced endometrioid ovarian carcinoma and was treated with
platinum-based neoadjuvant chemotherapy. After three cycles of
chemotherapy the patient had stable disease based on RECIST
assessment, pre- and post-chemotherapy CT imaging and a 92%
reduction of the tumour response marker CA125. She then
underwent interval debulking surgery but had residual tumour of
w1 cm at completion. After six moths she progressed with
platinum-resistant disease and died one month later.
Out of 20 biopsy samples 18 satisfied quality control for w50
tumour cellularity and array quality. The dataset included 14
omentum samples, two samples from the vaginal vault (VV) and
two samples from the external surface of the bladder (BL). The BL
and VV samples were taken prior to chemotherapy and the
omental samples were collected at interval-debulking surgery after
three cycles of chemotherapy.
All samples were copy-number profiled with Affymetrix SNP
6.0 arrays and segmented and compressed using PICNIC [24] and
CGHregions [55]. Pairwise evolutionary distances between all
samples were estimated with MEDICC. The distance distribution
was tested for the molecular clock hypothesis using MEDICC-
quant and showed strong non-clock like behaviour (pv10{10,
Figure 6A). Tree reconstruction was performed by MEDICC
using the Fitch-Margoliash algorithm Fitch1967. MEDICCquant
detected a high degree of clonal expansion (CE~1:24) as can be
seen in the strong spatial clustering of samples on the mutational
landscape (Figure 6B). MEDICC counted a median of 204
genomic events relative to the diploid and a median of 146
between all pairwise comparisons. Tree reconstruction showed
good support values for the omental and BL/VV subclades,
suggesting strong spatial heterogeneity. The patient also showed
strong temporal heterogeneity, as there were large evolutionary
distances between samples before and after neoadjuvant chemo-
therapy (temporal heterogeneity index 3.78, Figure 6B). However,
temporal and spatial heterogeneity in this case are indistinguishable
because the BL/VV samples coincide with the biopsy samples,
whereas all omentum samples were taken at surgery.
Ancestral reconstructions using MEDICC showed loss-of-
heterozygosity (LOH) events on chromosome 17q (see internal
node profiles in Figure 6A) that often coincide with deleterious
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mutations in BRCA1 and TP53 [56]. The most prominent
contributors to the clonal expansions of the subgroup surrounding
sample S01 seemed to be chromosomal amplifications on chro-
mosomes 6, 8, 11 and 14; as well as LOH on chromosome 15. We
also detected large LOH events on chromosomes 4, 5, 9, 10, 13,
14, 16 and 17 (Figure 6C).
Discussion
While significant progress has been made recently to understand
tumour heterogeneity through extensive multiple sampling studies
and experimental efforts, few algorithms have been developed to
target the specific questions raised by such datasets. MEDICC is
our contribution to better reconstruct the evolutionary histories of
cancer within a patient and propose unbiased quantification of
heterogeneity and the degree of clonal expansion.
We have shown the success of these efforts in simulations and
their utility in the example discussed in this article. More detailed
analyses of clinical cases that also elaborate on the connection
between clonal expansions and patient outcome can be found in
our clinical study [28].
It is important to note that both the clonal expansion index and
the proposed measure for average evolutionary distance between
subsets of samples are based solely on pairwise distances and the
implicit feature space projection and not on the reconstructed
trees. This is advantageous as e.g. for the temporal heterogeneity
index the subsets of samples that are compared are not necessarily
monophyletic clades in the tree.
As discussed above we attribute the increase in reconstruction
accuracy mainly to two factors. First, MEDICC makes efficient
use of the available phylogenetic information by phasing parental
alleles using the minimum evolution criterion, which has to our
knowledge not been attempted before. Second, MEDICC models
actual genomic events that change copy-number and incorporates
biological constraints such as loss-of heterozygosity, which is not
the case in breakpoint-based approaches.
The loss of reconstruction accuracy of TuMult relative even to
naive approaches using Euclidean distances is most likely due to
the fact that TuMult was designed for fewer leaf nodes (typically
around 4; Letouze, personal communication). It is worth stressing that,
unlike its competitors, MEDICC is not linked to a specific data
Figure 6. Application to a case of endometrioid cancer. A) Evolutionary tree of the OV03-04 case reconstructed from whole genome copy-
number profiles. Approximate support values indicate how often each split was observed in trees reconstructed after resampling of the distance
matrix with added truncated Gaussian noise. MEDICC performs reconstruction of ancestral copy-number profiles. Here, the (compressed) ancestral
profiles for chromosome 17 are given as an example and MEDICC depicts unresolved ambiguities in the form of sequence logos. A star indicates no
change compared to its ancestor. B) Ordination of the samples using kPCA shows four clear clonal expansions, comprising three separate Omentum
groups and the Bl/VV group. C) Circos plot of selected genomic profiles (marked in bold in the tree) shows the extent of chromosomal aberrations
across the genome. The two phased parental alleles are indicated in red and blue.
doi:10.1371/journal.pcbi.1003535.g006
Quantification of Tumour Heterogeneity
PLOS Computational Biology | www.ploscompbiol.org 9 April 2014 | Volume 10 | Issue 4 | e1003535
collection platform. Data from SNP arrays can be used, as well as
sequencing-based datasets or any other method that returns
absolute copy numbers. It is further worth noting that an increase
in K , the maximum allelic copy-number, first of all increases the
alphabet size but not the complexity of the algorithms. However,
increasing K also increase the number of states in the tree FST
T and hence the memory demands on the elementary FST
operations determinisation and minimisation [34] that are used when
constructing T . This effectively caps K at a value of 6 for the time
being.
Future work will focus on reductions of algorithmic complexity
as well as the integration of SNV data into the reconstruction
process. Another important aspect is subclonality within a physical
sample which may not easily lead to integer-based copy number
inference. Instead of fully clonal integer CN profiles we are
working on an extension that allows for mixtures of cells to be
represented effectively, allowing for the computation of expected
sequence similarities between mixtures of cancer genomes.
Additionally, it would certainly be desirable to move from the
current minimum-evolution approach to a full probabilistic model
with specific probabilities for amplification and deletion events.
Event probabilities could then be trained by expectation-max-
imisation. However, this significantly increases the computational
complexity of the algorithm, which demands the development of
new heuristics that constrain the size of intermediate results of the
reconstruction process.
Another consequence of this minimum-evolution approach is
that all events are weighted equally, independent of their size,
while computing evolutionary distances. During ancestral recon-
struction, however, if two possible ancestors would yield the same
total number of events in the tree, the algorithm prefers shorter
events over longer ones to reduce the ambiguity when determining
ancestral genomes. Preferring shorter events is a direct conse-
quence of our minimum evolution approach. However, if two
genomes differ by a focal deletion in a key gene that confers a
substantial fitness advantage, this fitness-increasing mutation will
most likely not be visible when determining the clonal expansion
index due to its relative small evolutionary distance to the other
genomes. Future work might explore the possibility of weighting
individual events based on their genomic position and the
potential oncogenes and tumour suppressors contained therein.
Lastly, MEDICC is subject to the same limitations as classical
algorithms for phylogenetic reconstructions. Strong convergent
evolution, i.e. two genomes becoming similar due to selection even
though they diverged early, can in theory mislead the reconstruc-
tion process. However, this problem is typically more pronounced
for point mutations than for copy-number changes. Two
convergent copy-number events that occurred independently must
by chance have the same start and end locus on the genome to be
considered identical, which is much less likely than two point
mutations occurring by chance at the same genomic position, due
to the far greater number of possible outcomes of each event.
Methods
SNP array data for the example from the OV03/04 study can
be accessed at the NCBI Gene Expression Omnibus under
accession number GSE40546.
Simulation of tumour evolution
Coalescent trees were simulated using the APE R package [44].
Simulation of genome evolution on these trees was performed by
custom code, released as the SimCopy R package [43]. SimCopy relies
on the PhyloSim package [57] in order to perform the simulations on
the level of abstract ‘‘genomic regions’’. The genomic regions are
encoded in a sequence of integers, with the sign representing their
orientation. The package then uses modified PhyloSim processes in
order to simulate deletion, duplication, inversion, inverted duplica-
tion and translocation events happening with rates specified by the
user. The number of genomic regions affected by each of these events
is modelled by truncated Geometric+1 distributions. After simulating
genome evolution, copy-number profiles are reported for leaf and
internal nodes. Genomes were simulated using 15 leaf nodes, a root
size of 100 segments and an average event length of 12 segments to
allow for overlapping events. Event rates covered the following set:
0:02,0:03,0:04,0:05,0:07,0:1,0:13,0:15,0:18,0:2: Individual event
rates were modified with the following factors: deletions: 0:3,
duplications: 1:0, inverted duplications: 0:1, inversions: 0:2, translo-
cations: 0:2. All parameters were chosen such that the leaf node copy-
number distributions are similar in shape to copy-number distribu-
tions from experimental data in the clinical study [28].
Implementation of MEDICC
All FST and FSA algorithms were implemented using
OpenFST [40]. MEDICC was written in Python, while imple-
mentation of time-critical parts used C. For the Fitch-Margoliash
implementations we used the Phylip package [58]. MEDICC is
available at https://bitbucket.org/rfs/medicc and has been tested
on Windows and UNIX-based systems.
The quantitative analysis of MEDICC results was done in R
and all necessary functions are implemented in the MEDICCquant
package included in the MEDICC distribution. Spatial statistics
were computed using the spatstat package [52], and for kernel
manipulations the kernlab package was used [59].
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